サイトメガロウイルスワクチンのグローバル市場機会分析(MarketVIEW: Cytomegalovirus vaccines)...市場調査レポートについてご紹介

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

★目次PDFファイル⇒http://h-and-i.main.jp/market-report/Vaczine/VAMV014.pdf

****This product is composed of a model and summary presentation

【Contents – Summary presentation (MS PowerPoint based)】

Executive summary
Key model outputs
CMV preconception vaccine: available market ($000s) to 2035
CMV transplant vaccine: available market ($000s) to 2035
CMV preconception vaccine: demand (000s doses) to 2035
CMV transplant vaccine: demand (000s doses) to 2035
CMV preconception vaccine: coverage scenarios
CMV vaccine: modelling assumptions/rationale
The role of CMV vaccine(s)
Target populations: CMV preconception vaccine
Target populations: CMV transplant vaccine
Target groups by serological risk profile
Pricing: CMV preconception vaccine
Pricing: CMV transplant vaccine
Target product profile: CMV preconception vaccine
Target product profile: CMV transplant vaccine
Key commercial model assumptions: preconception vaccine
Key commercial model assumptions: transplant vaccine
Markets included in the model
Model forecast comparisons: June 2010 v current
CMV vaccines: R&D pipeline
Competitor landscape: overview
Vical/Astellas: TransVax and CyMVectin
GSK: preconception CMV vaccine
Novartis/AlphaVax: alphavirus replicon CMV vaccine
Sanofi Pasteur: CMV gB vaccine
Other vaccine candidates
Vaccine pipeline summary
Estimated launch dates: vaccines + mAbs
CMV: review of current epidemiology
Epidemiology: transplants
Epidemiology: congenital CMV infection
Appendix I: Quantifying CMV populations
Methodology: HSCTs populations (by age and serostatus)
Methodology: solid organ transplant populations (by age and serostatus)
Methodology: preconception vaccine
Other supporting data
Prevalence of CMV in the US general population
Prevalence of CMV in other general populations.
Prevalence of CMV in transplant donors and recipients
AIDS patients with CMV retinitis
Prevalence of CMV in pregnant populations
Symptomatic newborns
Management of CMV disease after solid organ transplantation
Management of CMV infection in HSCT
Use of prophylactic/pre-emptive antivirals in HSCTs
Management of CMV retinitis in patients with AIDS
Treatment of congenital CMV in newborns
References/bibliography
About VacZine Analytics
Disclaimer

※PAGES: 60 MS PowerPoint slides, fully referenced/sourced. Available in .pdf form

【Contents – Vaccine demand model (MS Excel-based)】

Title sheet
Scenarion definitions
GRAND SUMMARY CHARTS
CHARTS VALUE
CHARTS VOLUME
CHARTS VOLUME – HIGH
VALUE SUMMARY
VOLUME SUMMARY
Preconception vaccine – females
Country volume/population sheets
US
Canada
UK
Germany
France
Spain
Italy
Other EU
Japan
Transplant vaccine – females
Country volume/population sheets
US
Canada
UK
Germany
France
Spain
Italy
Other EU
Japan
Source material
HSCTs by serostatus
Forecast HSCTs
Forecast HSCTs
Kidney and Liver TX base
Forecast Kidney TX
Forecast liver Tx
SOT by serostatus
Populations
Back page
About VacZine Analytics
Disclaimer


【レポート販売概要】

■ タイトル:サイトメガロウイルスワクチンのグローバル市場機会分析(MarketVIEW: Cytomegalovirus vaccines)
■ 発行日:2014年4月
■ 調査会社:VacZine Analytics
■ 商品コード:VAMV014
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。